pentosidine has been researched along with Alzheimer Disease in 8 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 3 (37.50) | 18.2507 |
2000's | 2 (25.00) | 29.6817 |
2010's | 3 (37.50) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Fülöp, T; Haddad, M; Landri, S; Lepage, A; Perrotte, M; Ramassamy, C | 1 |
Borghi, R; Monacelli, F; Odetti, P; Pacini, D; Serrati, C; Traverso, N | 1 |
Borghi, R; Cammarata, S; Monacelli, F; Nencioni, A; Odetti, P; Piccini, A; Tabaton, M | 1 |
Chamson, A; Denis, C; Ferron, C; Frey, J; Gonthier, R; Laurent, B; Meli, M; Parssegny, F; Perier, C; Reynaud, E | 1 |
Miyata, S; Monnier, VM; Perry, G; Richey, PL; Sayre, LM; Smith, MA; Stern, D; Taneda, S; Yan, SD | 1 |
Horie, K; Kurokawa, K; Maeda, K; Miyata, T; Sobue, G; Takeda, A; Yasuda, T; Yasuda, Y | 1 |
Doyu, M; Goto, Y; Horie, K; Inagaki, T; Maeda, K; Miyata, T; Sobue, G; Takeda, A; Wakai, M; Watanabe, M; Yasuda, T; Yasuda, Y | 1 |
Angelini, G; Garibaldi, S; Marinelli, L; Menini, S; Norese, R; Odetti, P; Perry, G; Siedlak, S; Smith, MA; Tabaton, M; Traverso, N; Valentini, S; Zaccheo, D | 1 |
8 other study(ies) available for pentosidine and Alzheimer Disease
Article | Year |
---|---|
Circulating and Extracellular Vesicles Levels of N-(1-Carboxymethyl)-L-Lysine (CML) Differentiate Early to Moderate Alzheimer's Disease.
Topics: Aged; Aged, 80 and over; Alzheimer Disease; Arginine; Biomarkers; Cell Line; Diagnosis, Differential; Disease Progression; Extracellular Vesicles; Female; Glycation End Products, Advanced; Humans; Lysine; Male; Mental Status and Dementia Tests; Neurons | 2019 |
Pentosidine determination in CSF: a potential biomarker of Alzheimer's disease?
Topics: Adult; Aged; Aged, 80 and over; Alzheimer Disease; Amyloid beta-Peptides; Arginine; Biomarkers; Chromatography, High Pressure Liquid; Enzyme-Linked Immunosorbent Assay; Female; Humans; Lysine; Male; Middle Aged; Peptide Fragments | 2014 |
Amnestic mild cognitive impairment and conversion to Alzheimer's disease: insulin resistance and glycoxidation as early biomarker clusters.
Topics: Aged; Alzheimer Disease; Arginine; Blood Glucose; Case-Control Studies; Cognitive Dysfunction; Disease Progression; Female; Humans; Insulin; Insulin Resistance; Lysine; Male; Malondialdehyde; Neuropsychological Tests; Psychiatric Status Rating Scales; Statistics as Topic | 2015 |
Serum pentosidine as an indicator of Alzheimer's disease.
Topics: Aged; Alzheimer Disease; Arginine; Biomarkers; Chromatography, High Pressure Liquid; Female; Humans; Lysine; Male; Predictive Value of Tests; Reference Values; Serum Albumin | 2002 |
Advanced Maillard reaction end products are associated with Alzheimer disease pathology.
Topics: Alzheimer Disease; Arginine; Enzyme-Linked Immunosorbent Assay; Glycation End Products, Advanced; Hippocampus; Humans; Immunoenzyme Techniques; Lysine; Maillard Reaction; Neurofibrillary Tangles; Norleucine; Pyrroles | 1994 |
Immunohistochemical localization of advanced glycation end products, pentosidine, and carboxymethyllysine in lipofuscin pigments of Alzheimer's disease and aged neurons.
Topics: Adolescent; Aged; Aging; Alzheimer Disease; Arginine; Glycation End Products, Advanced; Humans; Immunohistochemistry; Lipofuscin; Lysine; Nerve Degeneration; Nerve Tissue Proteins; Neurons | 1997 |
Advanced glycation end products co-localized with astrocytes and microglial cells in Alzheimer's disease brain.
Topics: Aged; Aged, 80 and over; Alzheimer Disease; Arginine; Astrocytes; Cytoplasmic Granules; Extracellular Space; Glycoconjugates; Hippocampus; Humans; Lysine; Microglia; Staining and Labeling | 1998 |
Lipoperoxidation is selectively involved in progressive supranuclear palsy.
Topics: Aged; Aldehydes; Alzheimer Disease; Arginine; Glycation End Products, Advanced; Humans; Immunohistochemistry; Lipid Peroxides; Lysine; Mesencephalon; Middle Aged; Norleucine; Pyrroles; Reference Values; Supranuclear Palsy, Progressive; tau Proteins; Thiobarbituric Acid Reactive Substances | 2000 |